“…This attribute of polymorph II is in agreement with Rustichelli et al 2000 andNaima et al 2001. There is consensus in the literature that CBZ crystallizes to three forms, at least: a trigonal (form II), a monoclinic (form III), and a high-temperature phase (form I) (Krahn and Mielck 1989).…”
“…This attribute of polymorph II is in agreement with Rustichelli et al 2000 andNaima et al 2001. There is consensus in the literature that CBZ crystallizes to three forms, at least: a trigonal (form II), a monoclinic (form III), and a high-temperature phase (form I) (Krahn and Mielck 1989).…”
“…Most of the cocrystals showed much lower melting points than T m of CBZ form I (190°C). As a heat-sensitive drug, there are many reports focused on its decomposition at high temperature (17,18).…”
By in-situ forming cocrystal, chemically stable amorphous solid dispersions were prepared by MM and HME at a depressed processing temperature. This method provides an attractive opportunity for HME of heat-sensitive drugs.
“…[4][5][6][7] In the past 20 years, investigations of CBZ have focused on the in vitro dissolution behavior and in vivo bioavailability of the drug where dissolution tests were employed in most studies. 5,[8][9][10][11][12][13][14] It was found that different CBZ forms have different physico-chemical properties 7,[15][16][17] and dissolution profiles with CBZ dihydrate (DH) showing the slowest dissolution rate and solubility (approximately two thirds of that of CBZ form III). 4 Also, dissolution testing of different sources of marketed CBZ tablets stored at varying temperature and humidity conditions has been carried out.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.